Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by JANICE NICOLE CORMIER and BARRY W FEIG.
JANICE NICOLE CORMIER
Connection Strength
3.540
BARRY W FEIG
  1. Radiation and Its Impact on Local Recurrence in Extremity and Trunk Well-Differentiated Liposarcomas. Am Surg. 2019 Jan 01; 85(1):52-58.
    View in: PubMed
    Score: 0.173
  2. Nongastrointestinal Stromal Tumor Spindle Cell Sarcomas of the Colon or Rectum. Am Surg. 2018 Apr 01; 84(4):570-575.
    View in: PubMed
    Score: 0.164
  3. Salvage Surgery for Recurrent Retroperitoneal Well-Differentiated Liposarcoma: Early Reoperation may not Provide Benefit. Ann Surg Oncol. 2018 Aug; 25(8):2193-2200.
    View in: PubMed
    Score: 0.164
  4. Identification of preoperative factors associated with outcomes following surgical management of intra-abdominal recurrent or metastatic GIST following neoadjuvant tyrosine kinase inhibitor therapy. J Surg Oncol. 2018 Apr; 117(5):879-885.
    View in: PubMed
    Score: 0.163
  5. Concomitant organ resection does not improve outcomes in primary retroperitoneal well-differentiated liposarcoma: A retrospective cohort study at a major sarcoma center. J Surg Oncol. 2018 May; 117(6):1188-1194.
    View in: PubMed
    Score: 0.161
  6. Recurrence patterns of retroperitoneal leiomyosarcoma and impact of salvage surgery. J Surg Oncol. 2017 Sep; 116(3):313-319.
    View in: PubMed
    Score: 0.155
  7. Accuracy of preoperative percutaneous biopsy for the diagnosis of retroperitoneal liposarcoma subtypes. Ann Surg Oncol. 2015 Apr; 22(4):1068-72.
    View in: PubMed
    Score: 0.130
  8. Association between travel distance and metastatic disease at diagnosis among patients with colon cancer. J Clin Oncol. 2014 Mar 20; 32(9):942-8.
    View in: PubMed
    Score: 0.123
  9. Association between adherence to National Comprehensive Cancer Network treatment guidelines and improved survival in patients with colon cancer. Cancer. 2013 Apr 15; 119(8):1593-601.
    View in: PubMed
    Score: 0.114
  10. Varying malignant potential of appendiceal neuroendocrine tumors: importance of histologic subtype. J Surg Oncol. 2013 Feb; 107(2):136-43.
    View in: PubMed
    Score: 0.110
  11. Adherence to stage-specific treatment guidelines for patients with colon cancer. J Clin Oncol. 2012 Mar 20; 30(9):972-9.
    View in: PubMed
    Score: 0.108
  12. Development and validation of a novel stratification tool for identifying cancer patients at increased risk of surgical site infection. Ann Surg. 2012 Jan; 255(1):134-9.
    View in: PubMed
    Score: 0.107
  13. Young-onset colorectal cancer: is it time to pay attention? Arch Intern Med. 2012 Feb 13; 172(3):287-9.
    View in: PubMed
    Score: 0.106
  14. Radiographic and clinical factors associated with improved outcomes in advanced cancer patients with bowel obstruction. J Palliat Med. 2011 Sep; 14(9):990-6.
    View in: PubMed
    Score: 0.103
  15. Isolated limb perfusion for unresectable extremity sarcoma: results of 2 single-institution phase 2 trials. Cancer. 2011 Jul 15; 117(14):3235-41.
    View in: PubMed
    Score: 0.100
  16. Clinical outcomes of molecularly confirmed clear cell sarcoma from a single institution and in comparison with data from the Surveillance, Epidemiology, and End Results registry. Cancer. 2009 Jul 01; 115(13):2971-9.
    View in: PubMed
    Score: 0.090
  17. Lymphadenectomy for isolated lymph node metastasis from extremity soft-tissue sarcomas. Cancer. 2008 Apr 15; 112(8):1821-6.
    View in: PubMed
    Score: 0.082
  18. Management of bevacizumab-associated bowel perforation: a case series and review of the literature. Ann Oncol. 2008 Mar; 19(3):577-82.
    View in: PubMed
    Score: 0.080
  19. Surgical resection of gastrointestinal stromal tumors after treatment with imatinib. Ann Surg Oncol. 2007 Jan; 14(1):14-24.
    View in: PubMed
    Score: 0.075
  20. Angiosarcoma of the breast. Cancer. 2005 Dec 15; 104(12):2682-8.
    View in: PubMed
    Score: 0.070
  21. Is there a role for surgery in patients with "unresectable" cKIT+ gastrointestinal stromal tumors treated with imatinib mesylate? Am J Surg. 2003 Dec; 186(6):665-9.
    View in: PubMed
    Score: 0.061
  22. Concurrent ifosfamide-based chemotherapy and irradiation. Analysis of treatment-related toxicity in 43 patients with sarcoma. Cancer. 2001 Sep 15; 92(6):1550-5.
    View in: PubMed
    Score: 0.052
  23. Postoperative pancreatic fistula after distal pancreatectomy for non-pancreas retroperitoneal tumor resection. Am J Surg. 2020 07; 220(1):140-146.
    View in: PubMed
    Score: 0.046
  24. An Evaluation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) Staging System for Retroperitoneal Sarcomas Using the National Cancer Data Base (NCDB): Does Size Matter? Am J Clin Oncol. 2019 02; 42(2):160-165.
    View in: PubMed
    Score: 0.044
  25. Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma. Cancer. 2018 12 01; 124(23):4495-4503.
    View in: PubMed
    Score: 0.043
  26. Comparative Performance of the 7th and 8th Editions of the American Joint Committee on Cancer Staging Systems for Soft Tissue Sarcoma of the Trunk and Extremities. Ann Surg Oncol. 2018 May; 25(5):1126-1132.
    View in: PubMed
    Score: 0.041
  27. Racial disparities in preoperative chemotherapy use in gastric cancer patients in the United States: Analysis of the National Cancer Data Base, 2006-2014. Cancer. 2018 03 01; 124(5):998-1007.
    View in: PubMed
    Score: 0.041
  28. Defining the incidence and clinical significance of lymph node metastasis in soft tissue sarcoma. Eur J Surg Oncol. 2018 01; 44(1):170-177.
    View in: PubMed
    Score: 0.040
  29. Adherence to National Comprehensive Cancer Network Guidelines is Associated with Improved Survival for Patients with Stage 2A and Stages 2B and 3 Extremity and Superficial Trunk Soft Tissue Sarcoma. Ann Surg Oncol. 2017 Oct; 24(11):3271-3278.
    View in: PubMed
    Score: 0.039
  30. Clinical Observations and Molecular Variables of Primary Vascular Leiomyosarcoma. JAMA Surg. 2016 Apr; 151(4):347-54.
    View in: PubMed
    Score: 0.036
  31. Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors. J Neurosurg. 2017 Jan; 126(1):319-329.
    View in: PubMed
    Score: 0.036
  32. Analysis of Clinical and Molecular Factors Impacting Oncologic Outcomes in Undifferentiated Pleomorphic Sarcoma. Ann Surg Oncol. 2016 07; 23(7):2220-8.
    View in: PubMed
    Score: 0.035
  33. Adequacy of the National Quality Forum's Colon Cancer Adjuvant Chemotherapy Quality Metric: Is 4 Months Soon Enough? Ann Surg. 2015 Aug; 262(2):312-20.
    View in: PubMed
    Score: 0.034
  34. Phase 1 adaptive dose-finding study of neoadjuvant gemcitabine combined with radiation therapy for patients with high-risk extremity and trunk soft tissue sarcoma. Cancer. 2015 Oct 15; 121(20):3659-67.
    View in: PubMed
    Score: 0.034
  35. Survival After Resection of Gastrointestinal Stromal Tumor and Sarcoma Liver Metastases in 146 Patients. J Gastrointest Surg. 2015 Aug; 19(8):1476-83.
    View in: PubMed
    Score: 0.034
  36. Combined Modality Management of Retroperitoneal Sarcomas: A Single-Institution Series of 121 Patients. Int J Radiat Oncol Biol Phys. 2015 Sep 01; 93(1):158-65.
    View in: PubMed
    Score: 0.034
  37. Overtreatment of young adults with colon cancer: more intense treatments with unmatched survival gains. JAMA Surg. 2015 May; 150(5):402-9.
    View in: PubMed
    Score: 0.034
  38. Radiation-Associated Undifferentiated Pleomorphic Sarcoma is Associated with Worse Clinical Outcomes than Sporadic Lesions. Ann Surg Oncol. 2015 Nov; 22(12):3913-20.
    View in: PubMed
    Score: 0.033
  39. Risk-adjusted pathologic margin positivity rate as a quality indicator in rectal cancer surgery. J Clin Oncol. 2014 Sep 20; 32(27):2967-74.
    View in: PubMed
    Score: 0.032
  40. Analysis of prognostic factors impacting oncologic outcomes after neoadjuvant tyrosine kinase inhibitor therapy for gastrointestinal stromal tumors. Ann Surg Oncol. 2014 Aug; 21(8):2499-505.
    View in: PubMed
    Score: 0.031
  41. A novel risk-adjusted nomogram for rectal cancer surgery outcomes. JAMA Surg. 2013 Aug; 148(8):769-77.
    View in: PubMed
    Score: 0.030
  42. Long-term outcomes in patients with radiation-associated angiosarcomas of the breast following surgery and radiotherapy for breast cancer. Ann Surg Oncol. 2013 Apr; 20(4):1267-74.
    View in: PubMed
    Score: 0.028
  43. Neuroendocrine tumors of the colon and rectum: prognostic relevance and comparative performance of current staging systems. Ann Surg Oncol. 2013 Apr; 20(4):1170-8.
    View in: PubMed
    Score: 0.028
  44. A population-based study of the quality of care in the diagnosis of large (=5 cm) soft tissue sarcomas. Am J Clin Oncol. 2012 Oct; 35(5):455-61.
    View in: PubMed
    Score: 0.028
  45. Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base. Ann Surg Oncol. 2012 Sep; 19(9):2814-21.
    View in: PubMed
    Score: 0.027
  46. Incorporation of adjuvant therapy into the multimodality management of gastrointestinal stromal tumors of the stomach in the United States. Ann Surg Oncol. 2012 Jan; 19(1):184-91.
    View in: PubMed
    Score: 0.026
  47. Postoperative nomogram for survival of patients with retroperitoneal sarcoma treated with curative intent. Ann Oncol. 2010 Feb; 21(2):397-402.
    View in: PubMed
    Score: 0.022
  48. Complete soft tissue sarcoma resection is a viable treatment option for select elderly patients. Ann Surg Oncol. 2009 Sep; 16(9):2579-86.
    View in: PubMed
    Score: 0.022
  49. Attempted salvage resection for recurrent gastric or gastroesophageal cancer. Ann Surg Oncol. 2009 Jan; 16(1):42-50.
    View in: PubMed
    Score: 0.021
  50. Does neoadjuvant treatment for gastric cancer patients with positive peritoneal cytology at staging laparoscopy improve survival? Ann Surg Oncol. 2008 Oct; 15(10):2684-91.
    View in: PubMed
    Score: 0.021
  51. Long-term results of prospective trial of surgery alone with selective use of radiation for patients with T1 extremity and trunk soft tissue sarcomas. Ann Surg. 2007 Oct; 246(4):675-81; discussion 681-2.
    View in: PubMed
    Score: 0.020
  52. Toxicity and outcomes associated with surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with sarcomatosis. Ann Surg Oncol. 2007 Aug; 14(8):2309-18.
    View in: PubMed
    Score: 0.019
  53. Management of locally recurrent soft-tissue sarcoma after prior surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 2007 Mar 15; 67(4):1124-9.
    View in: PubMed
    Score: 0.019
  54. Retroperitoneal soft tissue sarcoma: an analysis of radiation and surgical treatment. Int J Radiat Oncol Biol Phys. 2007 Jan 01; 67(1):158-63.
    View in: PubMed
    Score: 0.019
  55. The effect of preoperative radiotherapy and reconstructive surgery on wound complications after resection of extremity soft-tissue sarcomas. Ann Surg Oncol. 2006 Sep; 13(9):1209-15.
    View in: PubMed
    Score: 0.018
  56. Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate- or high-grade retroperitoneal soft tissue sarcoma. Ann Surg Oncol. 2006 Apr; 13(4):508-17.
    View in: PubMed
    Score: 0.018
  57. Interval between surgery and radiotherapy: effect on local control of soft tissue sarcoma. Int J Radiat Oncol Biol Phys. 2004 Apr 01; 58(5):1461-7.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.